Terms: = Germ cell tumor AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Treatment
69 results:
1. Longitudinal Natural History Study of Children and Adults with Rare Solid tumors: Initial Results for First 200 Participants.
Ahmed S; Wedekind MF; Del Rivero J; Raygada M; Lockridge R; Glod JW; Flowers C; Thomas BJ; Bernstein DB; Kapustina OB; Jain A; Miettinen M; Raffeld M; Xi L; Tyagi M; Kim J; Aldape K; Malayeri AA; Kaplan RN; Allen T; Vivelo CA; Sandler AB; Widemann BC; Reilly KM;
Cancer Res Commun; 2023 Dec; 3(12):2468-2482. PubMed ID: 37966258
[TBL] [Abstract] [Full Text] [Related]
2. Genotype-Phenotype Correlations and Clinical Outcomes in 155 Cases of Pheochromocytoma and Paraganglioma.
Wang H; Papachristos AJ; Gill AJ; Clifton-Bligh R; Aniss AM; Glover A; Sywak M; Sidhu SB
World J Surg; 2023 Mar; 47(3):690-698. PubMed ID: 36550325
[TBL] [Abstract] [Full Text] [Related]
3. Atomoxetine Decreases Mitochondrial Biogenesis, Fission and Fusion In Human Neuron-like cells But Does Not Alter Antioxidant Defences.
Carreón-Trujillo S; Vázquez-González D; Corona JC
Cell Biochem Biophys; 2023 Mar; 81(1):105-115. PubMed ID: 36346546
[TBL] [Abstract] [Full Text] [Related]
4. PIKE-A Modulates Mitochondrial Metabolism through Increasing sdha Expression Mediated by STAT3/FTO Axis.
Sun M; Yan Q; Qiao Y; Zhao H; Wang Y; Shan C; Zhang S
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232604
[TBL] [Abstract] [Full Text] [Related]
5. Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas.
Lamy C; Tissot H; Faron M; Baudin E; Lamartina L; Pradon C; Al Ghuzlan A; Leboulleux S; Perfettini JL; Paci A; Hadoux J; Broutin S
J Clin Endocrinol Metab; 2022 Sep; 107(10):2801-2810. PubMed ID: 35948272
[TBL] [Abstract] [Full Text] [Related]
6. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
Kuo MJM; Nazari MA; Jha A; Pacak K
Front Endocrinol (Lausanne); 2022; 13():936178. PubMed ID: 35903274
[TBL] [Abstract] [Full Text] [Related]
7. Paraganglioma and other tumour detection rates in individuals with SDHx pathogenic variants by age of diagnosis and after the age of 50.
Greenberg SE; Holman R; Kohlmann W; Buchmann L; Naumer A
Clin Endocrinol (Oxf); 2021 Sep; 95(3):447-452. PubMed ID: 34255389
[TBL] [Abstract] [Full Text] [Related]
8. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract] [Full Text] [Related]
9. Modulating endothelial adhesion and migration impacts stem cell therapies efficacy.
Schäfer R; Schwab M; Siegel G; von Ameln-Mayerhofer A; Buadze M; Lourhmati A; Wendel HP; Kluba T; Krueger MA; Calaminus C; Scheer E; Dominici M; Grisendi G; Doeppner TR; Schlechter J; Finzel AK; Gross D; Klaffschenkel R; Gehring FK; Spohn G; Kretschmer A; Bieback K; Krämer-Albers EM; Barth K; Eckert A; Elser S; Schmehl J; Claussen CD; Seifried E; Hermann DM; Northoff H; Danielyan L
EBioMedicine; 2020 Oct; 60():102987. PubMed ID: 32942121
[TBL] [Abstract] [Full Text] [Related]
10. The Changing Paradigm of Head and Neck Paragangliomas: What Every Otolaryngologist Needs to Know.
Cass ND; Schopper MA; Lubin JA; Fishbein L; Gubbels SP
Ann Otol Rhinol Laryngol; 2020 Nov; 129(11):1135-1143. PubMed ID: 32486832
[TBL] [Abstract] [Full Text] [Related]
11. An Open-Label Study of the Safety and Efficacy of Tag-7 Gene-Modified tumor cells-Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal cell Cancer.
Novik AV; Danilova AB; Sluzhev MI; Nehaeva TL; Larin SS; Girdyuk DV; Protsenko SA; Semenova AI; Danilov AO; Moiseyenko VM; Georgiev GP; Baldueva IA
Oncologist; 2020 Sep; 25(9):e1303-e1317. PubMed ID: 32240562
[TBL] [Abstract] [Full Text] [Related]
12. Fertility preservation outcomes in women with gliomas: a retrospective case-control study.
Nordan T; Thomas AM; Ginsburg ES; Wen PY; Dolinko AV; Bortoletto P
J Neurooncol; 2020 Apr; 147(2):371-376. PubMed ID: 32060839
[TBL] [Abstract] [Full Text] [Related]
13. Vascular architecture mapping for early detection of glioblastoma recurrence.
Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
[TBL] [Abstract] [Full Text] [Related]
14. Malignant Intrarenal/Renal Pelvis Paraganglioma with Co-Occurring SDHB and ATRX Mutations.
Irwin T; Konnick EQ; Tretiakova MS
Endocr Pathol; 2019 Dec; 30(4):270-275. PubMed ID: 31705439
[TBL] [Abstract] [Full Text] [Related]
15. Elevated Endogenous sdha Drives Pathological Metabolism in Highly Metastatic Uveal Melanoma.
Chattopadhyay C; Oba J; Roszik J; Marszalek JR; Chen K; Qi Y; Eterovic K; Robertson AG; Burks JK; McCannel TA; Grimm EA; Woodman SE
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4187-4195. PubMed ID: 31596927
[TBL] [Abstract] [Full Text] [Related]
16. Cytotoxic effect of crude and purified pectins from Campomanesia xanthocarpa Berg on human glioblastoma cells.
Amaral SDC; Barbieri SF; Ruthes AC; Bark JM; Brochado Winnischofer SM; Silveira JLM
Carbohydr Polym; 2019 Nov; 224():115140. PubMed ID: 31472853
[TBL] [Abstract] [Full Text] [Related]
17. Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance.
Gómez AM; Soares DC; Costa AAB; Pereira DP; Achatz MI; Formiga MN
Arch Endocrinol Metab; 2019 Jul; 63(4):369-375. PubMed ID: 31365623
[TBL] [Abstract] [Full Text] [Related]
18. Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report.
Lemelin A; Lapoirie M; Abeillon J; Lasolle H; Giraud S; Philouze P; Ceruse P; Raverot G; Vighetto A; Borson-Chazot F
Medicine (Baltimore); 2019 Jul; 98(30):e16594. PubMed ID: 31348302
[TBL] [Abstract] [Full Text] [Related]
19. KIT mutation in a naïve succinate dehydrogenase-deficient gastric GIST.
Brcic I; Kashofer K; Skone D; Liegl-Atzwanger B
Genes Chromosomes Cancer; 2019 Nov; 58(11):798-803. PubMed ID: 31124195
[TBL] [Abstract] [Full Text] [Related]
20. A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.
O'Kane GM; Ezzat S; Joshua AM; Bourdeau I; Leibowitz-Amit R; Olney HJ; Krzyzanowska M; Reuther D; Chin S; Wang L; Brooks K; Hansen AR; Asa SL; Knox JJ
Br J Cancer; 2019 Jun; 120(12):1113-1119. PubMed ID: 31105270
[TBL] [Abstract] [Full Text] [Related]
[Next]
